Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
PEGASUS-TIMI 54 study of BRILINTA® meets primary endpoint in both 60mg and 90mg doses
-
MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology
-
LYNPARZA™ approved by the US food and drug administration for the treatment of advanced ovarian cancer in patients with germline BRCA-mutations
-
Lynparza™approved in the European Union as first-in-class treatment for advanced BRCA-mutated ovarian cancer
-
AstraZeneca and Amgen to present detailed results from Phase III AMAGINE-1™ study evaluating brodalumab in patients with moderate-to-severe plaque psoriasis
-
MOVENTIG® approved in the European Union for opioid-induced constipation
-
Jury verdict favours AstraZeneca in Nexium antitrust litigation
-
New Drug Application for IRESSA accepted by US Food and Drug Administration
-
AstraZeneca and Eli Lilly and Company initiate pivotal clinical trial for patients with early Alzheimer’s disease
-
AstraZeneca to collaborate with Cancer Research UK in screening for new cancer medicines at the AstraZeneca MRC UK Centre for Lead Discovery
Latest articles and press releases
All of our latest press releases and articles are available to explore
